CORC

浏览/检索结果: 共226条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Pharmacokinetics, mass balance, and metabolism of [C-14]vicagrel, a novel irreversible P2Y(12) inhibitor in humans 期刊论文
ACTA PHARMACOLOGICA SINICA, 2020, 页码: 12
作者:  Zheng, Yuan-dong;  Zhang, Hua;  Zhan, Yan;  Bian, Yi-cong;  Ma, Sheng
收藏  |  浏览/下载:42/0  |  提交时间:2021/05/24
Potent and rapid reversal of the von Willebrand factor inhibitor aptamer BT200 期刊论文
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 页码: 10
作者:  Zhu, Shuhao;  Gilbert, James C.;  Liang, Zicai;  Kang, Daiwu;  Li, Ming
收藏  |  浏览/下载:28/0  |  提交时间:2020/12/24
Optimization of P2Y(12) Antagonist Ethyl 6-(4-((Benzylsulfonyl)carbarnoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283) Led to the Discovery of an Oral Antiplatelet Agent with Improved Druglike Properties 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 62, 期号: 6, 页码: 3088-3106
作者:  Kong, Deyu;  Xue, Tao;  Guo, Bin;  Cheng, Jianjun;  Liu, Shunyin
收藏  |  浏览/下载:13/0  |  提交时间:2020/07/01
Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y(12) inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing 期刊论文
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 卷号: 127, 页码: 151-160
作者:  Li, Cai;  Zhang, Yifan;  Chen, Weili;  Lu, Youming;  Li, Wei
收藏  |  浏览/下载:102/0  |  提交时间:2019/01/08
Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis 期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 卷号: 15, 期号: 1
作者:  Zheng, Zongyu;  Cai, Lu;  Gozal, Evelyne;  Rane, Madhavi J.;  Fu, Yaowen
收藏  |  浏览/下载:19/0  |  提交时间:2019/12/05
Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis 期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 卷号: 15, 期号: 1
作者:  Zheng, Zongyu;  Ma, Tianjiao;  Lian, Xin;  Gao, Jialin;  Wang, Weigang
收藏  |  浏览/下载:19/0  |  提交时间:2019/12/05
Clopidogrel-associated genetic variants on inhibition of platelet activity and clinical outcome for acute coronary syndrome patients 期刊论文
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 卷号: 124, 期号: 1
作者:  Li, Xiaoye;  Wang, Zi;  Wang, Qibing;  Xu, Qing;  Lv, Qianzhou
收藏  |  浏览/下载:26/0  |  提交时间:2019/12/05
Chinese patients carrying two CYP2C19 LOFs have a more active state of P2Y(12)-G(i) signaling and larger MPV in post-clopidogrel platelets with acute coronary syndrome 期刊论文
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 卷号: 12, 期号: 7
作者:  Xu, Huajie;  Wu, Hongyi;  Zhao, Xin;  Zhang, Yan;  Chen, She
收藏  |  浏览/下载:18/0  |  提交时间:2019/12/05
CYP2C19  clopidogrel  P2Y(12)  VASP  Akt  MPV  
Beraprost sodium versus clopidogrel for preventing vascular thromboembolic events of arteriovenous fistula in uraemic patients: a retrospective study with a mean 3-year follow-up 期刊论文
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 卷号: 47, 期号: 1
作者:  Wan, Ziming;  Zhu, Ying;  Yang, Ruikun;  Zhang, Yongjian;  Yang, Chen
收藏  |  浏览/下载:45/0  |  提交时间:2019/12/05
Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y(12) inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing 期刊论文
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 卷号: 127
作者:  Liu, Cai;  Zhang, Yifan;  Chen, Weili;  Lu, Youming;  Li, Wei
收藏  |  浏览/下载:26/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace